Gabriel M Lobel

Title: Gabriel M Lobel: Innovator in Aluminum Hydroxyphosphate Adjuvant Preparation

Introduction

Gabriel M Lobel is a notable inventor based in Telford, PA (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the preparation of aluminum hydroxyphosphate adjuvants. His work is crucial for the development of effective vaccine formulations.

Latest Patents

Gabriel M Lobel holds a patent for a "Method for preparation of aluminum hydroxyphosphate adjuvant." This invention relates to methods for preparing amorphous aluminum hydroxyphosphate. The process involves co-mixing an aluminum salt and a phosphate solution at a constant ratio in the presence of a buffer. An excess of the phosphate solution is preferably used to act as a buffer, maintaining a constant pH during the reaction without active adjustment. This method is particularly applicable for large-scale manufacturing of aluminum phosphate adjuvants, which are essential in vaccine formulations that include protein or saccharide antigens. He has 1 patent to his name.

Career Highlights

Gabriel M Lobel is associated with Merck Sharp & Dohme Corporation, a leading global healthcare company. His role in the company has allowed him to contribute to innovative solutions in vaccine development and pharmaceutical sciences.

Collaborations

Throughout his career, Gabriel has collaborated with esteemed colleagues, including David S Thiriot and Patrick L Ahl. These collaborations have further enhanced the impact of his work in the field.

Conclusion

Gabriel M Lobel's contributions to the preparation of aluminum hydroxyphosphate adjuvants represent a significant advancement in vaccine technology. His innovative methods are vital for the large-scale production of effective vaccines, underscoring his importance in the pharmaceutical industry.